Weather Forecast


State Medicaid program to benefit from settlement

Email News Alerts

BISMARCK — North Dakota’s Medicaid program will receive nearly $3 million as part of a $1.2 billion national settlement that resolves claims against Johnson & Johnson and a subsidiary for their marketing of the antipsychotic drugs Risperdal and Invega. 


Get the full story
Subscribe or Log In

Are you a newspaper subscriber but you don't have a Digital Access account yet? Activate your account.

You will need your subscription account number and phone number. Not sure if you have an account? Call (701) 225-8111 and we can help you.

Forum News Service
The Forum Communications News Service is the premier news wire service covering the Upper Midwest, stretching from the oilfields of western North Dakota to the plains of South Dakota and to the shores of eastern Minnesota. For more information about the services we offer or to discuss content subscriptions, please contact us.